These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18293136)

  • 1. HIV patient insight on adhering to medication: a qualitative analysis.
    Beusterien KM; Davis EA; Flood R; Howard K; Jordan J
    AIDS Care; 2008 Feb; 20(2):244-52. PubMed ID: 18293136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Literacy, self-efficacy, and HIV medication adherence.
    Wolf MS; Davis TC; Osborn CY; Skripkauskas S; Bennett CL; Makoul G
    Patient Educ Couns; 2007 Feb; 65(2):253-60. PubMed ID: 17118617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study.
    Mohammadpour A; Yekta ZP; Nikbakht Nasrabadi AR
    Nurs Health Sci; 2010 Dec; 12(4):464-9. PubMed ID: 21210925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
    Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
    Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients and family care givers' experiences around highly active antiretroviral therapy (HAART).
    Sacajiu G; Raveis VH; Selwyn P
    AIDS Care; 2009 Dec; 21(12):1528-36. PubMed ID: 20024732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-related knowledge and adherence to HAART.
    Weiss L; French T; Finkelstein R; Waters M; Mukherjee R; Agins B
    AIDS Care; 2003 Oct; 15(5):673-9. PubMed ID: 12959818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time, self and the medication day: a closer look at the everyday work of 'adherence'.
    McCoy L
    Sociol Health Illn; 2009 Jan; 31(1):128-46. PubMed ID: 19170973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stigma and social barriers to medication adherence with urban youth living with HIV.
    Rao D; Kekwaletswe TC; Hosek S; Martinez J; Rodriguez F
    AIDS Care; 2007 Jan; 19(1):28-33. PubMed ID: 17129855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients.
    Murphy DA; Roberts KJ; Hoffman D; Molina A; Lu MC
    AIDS Care; 2003 Apr; 15(2):217-30. PubMed ID: 12856343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of adherence management in human immunodeficiency virus pharmacotherapy.
    Park-Wyllie LY; Phillips EJ
    Can J Clin Pharmacol; 2003; 10(4):189-95. PubMed ID: 14712324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.
    Fumaz CR; Muñoz-Moreno JA; Moltó J; Ferrer MJ; López-Blázquez R; Negredo E; Paredes R; Gómez G; Clotet B
    AIDS Care; 2008 Aug; 20(7):796-805. PubMed ID: 18728987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.
    Stone VE
    Clin Infect Dis; 2001 Sep; 33(6):865-72. PubMed ID: 11512092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M; Koffi CK
    AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART.
    Balfour L; Kowal J; Silverman A; Tasca GA; Angel JB; Macpherson PA; Garber G; Cooper CL; Cameron DW
    AIDS Care; 2006 Oct; 18(7):830-8. PubMed ID: 16971295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study.
    Small W; Wood E; Betteridge G; Montaner J; Kerr T
    AIDS Care; 2009 Jun; 21(6):708-14. PubMed ID: 19806487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to antiretroviral medication adherence in HIV-infected women.
    Roberts KJ; Mann T
    AIDS Care; 2000 Aug; 12(4):377-86. PubMed ID: 11091770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric adherence: perspectives of mothers of children with HIV.
    Wrubel J; Moskowitz JT; Richards TA; Prakke H; Acree M; Folkman S
    Soc Sci Med; 2005 Dec; 61(11):2423-33. PubMed ID: 15936134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives Regarding Adherence to Prescribed Treatment in Highly Adherent HIV-Infected Gay Men.
    Brion JM; Menke EM
    J Assoc Nurses AIDS Care; 2008; 19(3):181-91. PubMed ID: 18457759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of antiretroviral adherence.
    Murphy DA; Marelich WD; Hoffman D; Steers WN
    AIDS Care; 2004 May; 16(4):471-84. PubMed ID: 15203415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.